His primary areas of study are Internal medicine, Gastroenterology, Hepatitis C, Cirrhosis and Ribavirin. His biological study spans a wide range of topics, including Surgery and Immunology. The study incorporates disciplines such as Adverse effect and Viral load in addition to Gastroenterology.
His Hepatitis C research incorporates elements of Hepatitis C virus, Viral hepatitis, Intensive care medicine, Hepatocellular carcinoma and Pharmacotherapy. His Hepatocellular carcinoma study integrates concerns from other disciplines, such as Carcinoma, Pathology and Ascites. His research integrates issues of Cytology and Liver biopsy in his study of Cirrhosis.
His primary scientific interests are in Internal medicine, Gastroenterology, Hepatitis C, Cirrhosis and Ribavirin. The concepts of his Internal medicine study are interwoven with issues in Endocrinology, Immunology and Hepatitis C virus. His Hepatology study in the realm of Gastroenterology interacts with subjects such as In patient.
His Hepatitis C research integrates issues from Chronic liver disease, Interferon, Liver function tests and Pathology. Timothy R. Morgan has included themes like Liver function, Liver transplantation, Liver biopsy, Clinical trial and Liver cancer in his Cirrhosis study. His Ribavirin research is classified as research in Genotype.
Timothy R. Morgan spends much of his time researching Internal medicine, Hepatitis C, Veterans Affairs, Alcoholic hepatitis and Cirrhosis. The various areas that Timothy R. Morgan examines in his Internal medicine study include Gastroenterology, MEDLINE and Alcohol use disorder. He studies Alanine aminotransferase, a branch of Gastroenterology.
His work deals with themes such as Nursing and Hepatitis C virus, which intersect with Hepatitis C. His Alcoholic hepatitis research also works with subjects such as
Timothy R. Morgan mainly investigates Internal medicine, Odds ratio, Hepatitis C virus, Cirrhosis and Hepatitis C. His Internal medicine research is multidisciplinary, relying on both Magnetic resonance imaging and Cardiac magnetic resonance imaging. His work carried out in the field of Odds ratio brings together such families of science as Clinical trial, Genome-wide association study, Disease, Diagnosis code and Cohort.
In general Hepatitis C virus study, his work on Sofosbuvir often relates to the realm of Member states, thereby connecting several areas of interest. His Hepatitis C study combines topics in areas such as Population health, Population Health Management and MEDLINE. His Ribavirin study deals with Veterans Affairs intersecting with Nursing and System redesign.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.
Hadziyannis Sj;Sette H;Morgan Tr;Balan.
Annals of Internal Medicine (2004)
A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST)
Walter H. Ettinger;Robert Burns;Stephen P. Messier;William Applegate.
JAMA (1997)
The natural history of hepatitis C virus (HCV) infection.
Stephen L. Chen;Timothy R. Morgan.
International Journal of Medical Sciences (2006)
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Ludmila Prokunina-Olsson;Brian Muchmore;Wei Tang;Ruth M Pfeiffer.
Nature Genetics (2013)
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
Anna S. Lok;Leonard B. Seeff;Timothy R. Morgan;Adrian M. di Bisceglie.
Gastroenterology (2009)
Alcohol and hepatocellular carcinoma.
Timothy R. Morgan;Timothy R. Morgan;Sarathy Mandayam;Sarathy Mandayam;M. Mazen Jamal;M. Mazen Jamal.
Gastroenterology (2004)
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
Mitchell L. Shiffman;Adrian M. Di Bisceglie;Karen L. Lindsay;Chihiro Morishima.
Gastroenterology (2004)
A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
John R. Crouse;Timothy Morgan;James G. Terry;Julie Ellis.
JAMA Internal Medicine (1999)
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy†‡§
Donald M. Jensen;Timothy R. Morgan;Patrick Marcellin;Paul J. Pockros.
Hepatology (2006)
Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial
Dalane W. Kitzman;Peter Brubaker;Timothy Morgan;Mark Haykowsky.
JAMA (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Otago
UCLA Medical Center
National Institutes of Health
Wake Forest University
Harvard University
Bon Secours Health System
University of Colorado Denver
The University of Texas Southwestern Medical Center
National Institutes of Health
Saint Louis University
AGH University of Science and Technology
Universitat Politècnica de València
University of Melbourne
Russian Academy of Sciences
University of Utah
Stanford University
National Institutes of Health
Zhejiang Chinese Medical University
University of Guelph
Institut Pasteur
Agency for Science, Technology and Research
Yale University
University of Montreal
University of North Carolina at Chapel Hill
University of South Carolina
Brigham and Women's Hospital